z-logo
open-access-imgOpen Access
Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Author(s) -
Paul M. Ridker
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.097907
Subject(s) - triglyceride , medicine , test (biology) , triglycerides blood , endocrinology , cholesterol , biology , paleontology
Historically, triglycerides have been measured in the fasting state for 2 reasons. First, because of the marked increaseintriglyceridesafterfatingestion,thevariabil- ity in triglyceride measurements is much smaller in the fasting state. Second, before the availability of direct assays for LDL cholesterol (LDL-C),1 estimation of LDL-Cwasperformedinclinicalpracticealmostexclu- sively by use of the Friedewald equation, which re- quires that both the HDL-C concentration and the fasting triglyceride concentration divided by 5 be sub- tracted from the total cholesterol concentration. The recommendations to measure triglycerides in the fasting state did not, however, derive from a con- sistent set of prospective cohort studies showing that fasting concentrations were superior to nonfasting concentrations for the detection of cardiovascular risk. Instead, following screening guidelines, most epidemi- ologic investigations simply relied on fasting triglycer-

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom